• Investor Network: Chemocentryx, Inc. to Host Earnings Call ACCESS Newswire Tue, 29 Apr 2025 19:19:15 GMT
• ATyr hires ex-ChemoCentryx commercial chief for planned launch Fierce Pharma Wed, 26 Mar 2025 07:00:00 GMT
• 25-year pharma veteran joins atyr to launch first new sarcoidosis treatment in 70 years Stock Titan Wed, 26 Mar 2025 07:00:00 GMT
• anca vasculitis drug market witnessing growth | innovations & openPR Thu, 20 Feb 2025 08:00:00 GMT
• investor network: chemocentryx, inc. to host earnings call ACCESS Newswire Sun, 26 Jan 2025 13:38:33 GMT
• BeiGene Enters Sublease Agreement with ChemoCentryx for Expansion TipRanks Mon, 20 Jan 2025 08:00:00 GMT
• anca vasculitis pipeline forecast 2024: fda approvals, therapies, and leading companies by delveinsight | vifor pharma, glaxosmith... The Globe and Mail Thu, 19 Dec 2024 20:00:51 GMT
• anca-associated vasculitis market expected to experience major growth by 2034, according to delveinsight | amgen, glaxosmithkline,... Barchart Mon, 09 Dec 2024 15:45:12 GMT
• celiac disease market key players analysis - amgen, anokion sa, openPR Fri, 22 Nov 2024 08:00:00 GMT
• complement drug market size in 2024 | examining future growth scenarios and projections for 2032 WICZ Tue, 12 Nov 2024 05:49:00 GMT
• anca-associated vasculitis market expected to experience major growth by 2034, according to delveinsight | chemocentryx, amgen, gl... Barchart Mon, 28 Oct 2024 07:00:00 GMT
• anca-associated vasculitis market is predicted to exhibit remarkable growth during the forecast period (2024-2034), analyzes delve... Barchart Fri, 11 Oct 2024 14:38:00 GMT
• inflammatory bowel disease drugs market analysis on industry trends, drivers, application and segmentation 2024 to 2032 | chemocen... 대구포스트 Mon, 30 Sep 2024 11:03:25 GMT
• chemours (nyse:cc) price target lowered to $21.00 at barclays MarketBeat Wed, 25 Sep 2024 16:34:01 GMT
• is it too late to consider buying the chemours company (nyse:cc)? Simply Wall St Wed, 25 Sep 2024 11:20:29 GMT
• commvault systems, inc. (nasdaq:cvlt) shares sold by hsbc holdings plc MarketBeat Wed, 25 Sep 2024 08:16:21 GMT
• coherus biosciences, inc. (nasdaq:chrs) shares bought by xtx topco ltd Defense World Wed, 25 Sep 2024 08:08:16 GMT
• camping world cl a earns relative strength rating upgrade; hits key threshold Investor's Business Daily Wed, 25 Sep 2024 07:00:00 GMT
• investing in camping world holdings inc (cwh): what you must know Knox Daily Tue, 24 Sep 2024 20:12:15 GMT
• stocks of chemours company (cc) are poised to climb above their peers SETE News Tue, 24 Sep 2024 18:19:49 GMT
• jefferies lifts cognizant technology solutions corp. [ctsh] price estimate. who else is bullish? The DBT News Tue, 24 Sep 2024 14:12:29 GMT
• cognizant technology solutions co. (nasdaq:ctsh) stock holdings increased by bank of montreal can Defense World Tue, 24 Sep 2024 11:41:04 GMT
• evergreen capital management llc acquires 550 shares of cummins inc. (nyse:cmi) Defense World Tue, 24 Sep 2024 11:09:57 GMT
• cma cgm acquires 48% stake in santos brasil, expands presence in brazil Ships&Ports Tue, 24 Sep 2024 10:50:25 GMT
• seelos therapeutics inc (seel) quote - press release The Globe and Mail Tue, 24 Sep 2024 07:00:00 GMT
• chipotle mexican grill, inc. (nyse:cmg) position increased by beck capital management llc Defense World Mon, 23 Sep 2024 20:31:05 GMT
• morse asset management inc raises stock position in chipotle mexican grill, inc. (nyse:cmg) Defense World Mon, 23 Sep 2024 15:37:02 GMT
• itau unibanco holding s.a. buys shares of 2,551 the chemours company (nyse:cc) Defense World Mon, 23 Sep 2024 12:31:37 GMT
• cma cgm expands footprint in brazil with latest stake acquisition Offshore Energy Mon, 23 Sep 2024 11:23:09 GMT
• mutual of america capital management llc sells 2,592 shares of cognizant technology solutions co. (nasdaq:ctsh) Defense World Mon, 23 Sep 2024 09:54:10 GMT
• mutual of america capital management llc trims holdings in church & dwight co., inc. (nyse:chd) Defense World Mon, 23 Sep 2024 09:24:21 GMT
• westwood holdings group inc. buys 625,307 shares of chipotle mexican grill, inc. (nyse:cmg) Defense World Sun, 22 Sep 2024 23:25:30 GMT
• xtx topco ltd makes new $889,000 investment in churchill downs incorporated (nasdaq:chdn) MarketBeat Sun, 22 Sep 2024 08:49:34 GMT
• chubb stock trading near 52-week high: what should investors know? Yahoo Finance Fri, 20 Sep 2024 16:44:00 GMT
• church & dwight co., inc. (nyse:chd) shares purchased by hsbc holdings plc Defense World Fri, 20 Sep 2024 09:35:32 GMT
• camping world holdings inc [cwh] shares fall -0.21 % on wednesday Knox Daily Thu, 19 Sep 2024 22:03:35 GMT
• c5a anaphylatoxin chemotactic receptor 1 market – 37% of growth to originate from apac -affiris ag, chemocentryx, inc., – moose ga... Moose Gazette Thu, 01 Aug 2024 06:37:30 GMT
• c5a anaphylatoxin chemotactic receptor 1 market is going to boom |affiris ag, chemocentryx, inc., dompe farmaceutici s.p – moose g... Moose Gazette Tue, 30 Jul 2024 15:56:00 GMT
• global inflammatory bowel disease drugs market 2024 analysis by top key players |chemocentryx, novo nordisk The NRI News Tue, 30 Jul 2024 07:00:00 GMT
• vasculitis treatment market with tremendous growth by 2031 – glaxosmithkline plc, amneal pharmaceuticals, inc., chemocentryx, infl... TIMC Mon, 15 Jul 2024 17:19:40 GMT
• focal segmental glomerulosclerosis (fsgs) market is booming worldwide – variant pharmaceuticals, chemocentryx, retrophin, novartis... TIMC Mon, 15 Jul 2024 07:00:00 GMT
• anca vasculitis pipeline insights 2024: therapies, clinical trials, and clinical trials by delveinsight | vifor pharma, glaxosmith... Barchart Wed, 10 Jul 2024 07:00:00 GMT
• are options traders betting on a big move in chemocentryx (ccxi) stock? Yahoo Wed, 03 Jul 2024 11:57:39 GMT
• chemocentryx announces approval in japan of tavneos™ (avacopan) for the treatment of anca-associated ... Quantisnow Sun, 30 Jun 2024 21:10:35 GMT
• chemocentryx to present at two upcoming investor conferences Quantisnow Sun, 30 Jun 2024 11:23:19 GMT
• chemocentryx announces eu approval of tavneos® (avacopan) for the treatment of anca-associated vasculitis Quantisnow Sun, 30 Jun 2024 10:02:29 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo News Australia Sun, 30 Jun 2024 01:20:00 GMT
• chemocentryx inc. filed sec form 8-k: submission of matters to a vote of security holders Quantisnow Fri, 28 Jun 2024 03:26:56 GMT
• chemocentryx (ccxi) now trades above golden cross: time to buy? Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
• chemocentryx (ccxi) now trades above golden cross: time to buy? Yahoo Lifestyle Australia Mon, 24 Jun 2024 22:39:34 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo News Australia Mon, 24 Jun 2024 05:30:41 GMT
• atypical hemolytic uremic syndrome drug market analysis | akari therapeutics plc, alexion pharmaceuticals inc ... PrimePair Thu, 20 Jun 2024 14:43:55 GMT
• chemocentryx (ccxi) now trades above golden cross: time to buy? Yahoo Lifestyle Australia Thu, 20 Jun 2024 04:56:00 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo News Australia Thu, 20 Jun 2024 04:31:55 GMT
• complement drug market growth report | alexion pharmaceuticals, chemocentryx, roche, apellis – primepair PrimePair Wed, 19 Jun 2024 16:59:29 GMT
• chemocentryx (ccxi) shows strength: stock moves up 5.6% Yahoo News Malaysia Mon, 17 Jun 2024 18:44:53 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo News Australia Mon, 17 Jun 2024 08:30:17 GMT
• chemocentryx reports fourth quarter and full year 2020 financial results and recent highlights br.ADVFN.com Sat, 15 Jun 2024 07:29:06 GMT
• chemocentryx (ccxi) tavneos gets fda nod for anca vasculitis Yahoo Sport Australia Mon, 10 Jun 2024 19:16:32 GMT
• chemocentryx announces closing of public offering of common stock and full exercise of underwriters' option to ... br.ADVFN.com Thu, 06 Jun 2024 17:14:30 GMT
• chemocentryx and vfmcrp announce european medicines agency has accepted to review the marketing ... br.ADVFN.com Thu, 06 Jun 2024 14:28:26 GMT
• chemocentryx to hold second quarter 2016 financial results conference call on monday, august 8, 2016 br.ADVFN.com Thu, 06 Jun 2024 03:05:20 GMT
• chemocentryx (ccxi) upgraded to buy: what does it mean for the stock? Yahoo Lifestyle Australia Wed, 05 Jun 2024 13:04:01 GMT
• amgen to sublease 100k sf of life science offices in san carlos The Real Deal Mon, 03 Jun 2024 07:00:00 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo Lifestyle UK Sat, 01 Jun 2024 18:12:05 GMT
• chemocentryx announces peer-reviewed publication of positive phase 2 clinical data with ccx354, a novel ... br.ADVFN.com Sat, 01 Jun 2024 11:25:05 GMT
• chemocentryx to present at the cantor fitzgerald 2018 global healthcare conference br.ADVFN.com Sat, 01 Jun 2024 00:09:19 GMT
• chemocentryx to hold fourth quarter 2016 financial results conference call on tuesday, march 14, 2017 br.ADVFN.com Sat, 01 Jun 2024 00:02:18 GMT
• chemocentryx announces closing of public offering of common stock and full exercise of underwriters' over ... br.ADVFN.com Fri, 31 May 2024 22:36:21 GMT
• why is chemocentryx (ccxi) up 1.4% since last earnings report? Yahoo Movies Canada Fri, 31 May 2024 20:57:41 GMT
• Amgen opts to sublease Peninsula space taken in $3.9 billion buyout The Business Journals Thu, 30 May 2024 07:00:00 GMT
• the consensus eps estimates for chemocentryx, inc. (nasdaq:ccxi) just fell dramatically Yahoo Movies UK Mon, 27 May 2024 16:56:40 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo Lifestyle UK Thu, 23 May 2024 03:54:36 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo Lifestyle UK Sun, 19 May 2024 08:23:56 GMT
• here's why chemocentryx (ccxi) is a great momentum stock to buy Yahoo Singapore News Sat, 18 May 2024 14:18:25 GMT
• strength seen in chemocentryx (ccxi): can its 8.6% jump turn into more strength? Yahoo Lifestyle UK Fri, 17 May 2024 14:13:45 GMT
• chemocentryx (ccxi) q4 loss wider than expected, sales miss Yahoo Movies UK Tue, 07 May 2024 15:39:51 GMT
• myeloid cells targeting therapeutics industry research study |chemocentryx, daiichi sankyo, gilead sciences Motions Online Tue, 07 May 2024 08:03:31 GMT
• RA Capital sues ChemoCentryx after biotech company's $3.9 billion sale to Amgen The Business Journals Tue, 07 May 2024 07:00:00 GMT
• chemocentryx (ccxi) gets positive chmp opinion for tavneos Yahoo New Zealand News Mon, 06 May 2024 05:53:25 GMT
• chemocentryx (ccxi) q4 loss wider than expected, sales miss Yahoo Movies UK Sat, 04 May 2024 13:05:12 GMT
• [top players] myeloid cells targeting therapeutics market chemocentryx, daiichi sankyo, gilead sciences, janssen ... Motions Online Tue, 30 Apr 2024 01:24:35 GMT
• chemocentryx (ccxi) upgraded to buy: what does it mean for the stock? Yahoo Movies Canada Thu, 25 Apr 2024 11:33:00 GMT
• chemocentryx's avacopan scores european approval for anca-associated vasculitis AOL Wed, 24 Apr 2024 20:01:03 GMT
• chemocentryx (ccxi) moves to buy: rationale behind the upgrade Yahoo Canada Shine On Mon, 22 Apr 2024 14:15:39 GMT
• chemocentryx soars on phase iii avacopan data in anca vasculitis HBW Insight Wed, 17 Apr 2024 04:32:15 GMT
• chemocentryx (ccxi) moves to buy: rationale behind the upgrade Yahoo Canada Shine On Mon, 15 Apr 2024 17:03:26 GMT
• c5a anaphylatoxin chemotactic receptor 1 market development status 2030 | chemocentryx, inc., dompe ... Currency News Centre Sun, 14 Apr 2024 23:40:58 GMT
• complement drug market 2030 | alexion pharmaceuticals, chemocentryx, roche, apellis – currency news centre Currency News Centre Sun, 14 Apr 2024 15:13:52 GMT
• the five-year returns have been stellar for chemocentryx (nasdaq:ccxi) shareholders despite underlying losses ... Yahoo Movies Canada Sat, 13 Apr 2024 01:18:58 GMT
• changing standards of care trip up companies at us fda advisory committees Pink Sheet Sat, 06 Apr 2024 12:29:49 GMT
• the five-year returns have been stellar for chemocentryx (nasdaq:ccxi) shareholders despite underlying losses ... Yahoo Movies Canada Thu, 04 Apr 2024 03:18:48 GMT
• amgen bets on chemocentryx's rare disease drug in $3.7 billion deal Yahoo Movies UK Mon, 01 Apr 2024 07:13:10 GMT
• chemocentryx's nda for autoimmune disease drug accepted by fda Yahoo Movies Canada Mon, 25 Mar 2024 01:26:00 GMT
• chemocentryx receives fda orphan drug designation for avacopan in treatment of debilitating kidney disease Reuters.com Fri, 22 Mar 2024 07:00:00 GMT
• [top players] myeloid cells targeting therapeutics market chemocentryx, daiichi sankyo, gilead sciences, janssen ... Amoré Tue, 19 Mar 2024 00:19:23 GMT
• immuneering adds biotech veteran thomas schall to board by investing.com Investing.com Canada Tue, 12 Mar 2024 12:59:30 GMT
• immuneering corporation (imrx) appoints thomas j. schall, ph.d. to its board of directors StreetInsider.com Tue, 12 Mar 2024 07:00:00 GMT
• immuneering appoints thomas j. schall, ph.d. to its board of directors TradingView Tue, 12 Mar 2024 07:00:00 GMT
• should you buy chemocentryx (ccxi) ahead of earnings? Yahoo Movies UK Sun, 10 Mar 2024 05:21:04 GMT
• chemocentryx inc (ccxi) president and ceo thomas j. schall sold $1.9 million of shares AOL Sat, 02 Mar 2024 16:32:20 GMT
• atypical chemokine receptor 3 market is in huge demand:chemocentryx inc, jyant technologies inc, polyphor ltd ... Artrocker Tue, 30 Jan 2024 10:38:38 GMT
• c5a anaphylatoxin chemotactic receptor 1 market is going to boom |affiris ag, chemocentryx, inc., dompe ... Artrocker Tue, 30 Jan 2024 10:35:00 GMT
• c-c chemokine receptor type 4 market 2023 top industry players: affitech a/s, astrazeneca plc, chemocentryx inc ... The Nelson Post Tue, 23 Jan 2024 12:08:27 GMT
• c-x-c chemokine receptor type 2 market – industry trends and forecast to 2030 | key companies:astrazeneca plc ... The Nelson Post Tue, 23 Jan 2024 08:00:00 GMT
• atypical hemolytic uremic syndrome drug market analysis competitive landscape, growth factors, revenue ... Future of Media Fri, 12 Jan 2024 16:24:22 GMT
• atypical chemokine receptor 3 market developments 2030 |chemocentryx inc, jyant technologies inc, polyphor ltd Future of Media Fri, 12 Jan 2024 16:18:56 GMT
• c-c chemokine receptor type 4 market expected to grow exponentially by 2030 |affitech a/s, astrazeneca plc ... Future of Media Fri, 12 Jan 2024 16:18:56 GMT
• anca vasculitis drug rapidly growing market globally |chemocentryx, inc., glaxosmithkline plc, kineta, inc. – future ... Future of Media Fri, 12 Jan 2024 12:42:35 GMT
• complement drug market to witness massive growth by 2030 | novartis ag, alexion pharmaceuticals, chemocentryx ... Future of Media Thu, 11 Jan 2024 15:16:51 GMT
• Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYR... PR Newswire Wed, 10 Jan 2024 08:00:00 GMT
• hidradenitis suppurativa pipeline analysis covering clinical trials, emerging therapies, fda, ema, and pmda ap openPR Tue, 09 Jan 2024 16:12:00 GMT
• keep eyes on: archer-daniels-midland company (nyse:adm), banco santander, s.a. (nyse:san), chemocentryx ... TechNews.org Tue, 09 Jan 2024 15:11:09 GMT
• c5a anaphylatoxin chemotactic receptor 1 market – 37% of growth to originate from apac -affiris ag ... Rough Cut Reviews Thu, 04 Jan 2024 07:08:45 GMT
• atypical chemokine receptor 3 market worth $7.3 billion by 2030 -chemocentryx inc, jyant technologies inc ... Rough Cut Reviews Thu, 04 Jan 2024 07:07:58 GMT
• cbd hemp oil market 2023 by keyplayers and vendors: affitech a/s, astrazeneca plc, chemocentryx inc, corion ... Rough Cut Reviews Tue, 02 Jan 2024 11:52:52 GMT
• amgen sponsors rose parade float to support blossoming of kidney disease awareness Fierce Pharma Tue, 02 Jan 2024 08:00:00 GMT
• apol1 mediated kidney disease market analysis |vertex pharmaceuticals, ionis pharmaceuticals, travere ... Argyle Report Mon, 18 Dec 2023 16:47:22 GMT
• ers international congress 2017 - forma therapeutics, srp-9001 The Pharma Letter Mon, 18 Dec 2023 02:57:58 GMT
• c5 complement inhibitors market future outlook by 2030 | alexion, chemocentryx – salisburyandstonehenge salisburyandstonehenge Wed, 13 Dec 2023 09:33:14 GMT
• microscopic polyangiitis (mpa) treatment global market report |celltrion inc, chemocentryx inc, sandoz international ... Artrocker Wed, 13 Dec 2023 05:05:07 GMT
• vasculitis pipeline and clinical trials assessment 2023: fda approvals, therapies and key companies involved b openPR Mon, 11 Dec 2023 08:00:00 GMT
• cbd hemp oil market 2023 by keyplayers and vendors: affitech a/s, astrazeneca plc, chemocentryx inc, corion ... Artrocker Fri, 08 Dec 2023 07:29:22 GMT
• focal segmental glomerulosclerosis (fsgs) market high growth opportunities – variant pharmaceuticals ... salisburyandstonehenge Wed, 06 Dec 2023 18:37:12 GMT
• complement drug market growing massively by novartis ag, alexion pharmaceuticals, chemocentryx ... salisburyandstonehenge Sat, 02 Dec 2023 20:58:28 GMT
• c-c chemokine receptor type-4 market to witness explosive growth by 2030 – affitech a/s, astrazeneca plc ... salisburyandstonehenge Fri, 01 Dec 2023 09:10:31 GMT
• c-x-c chemokine receptor type-2 market growing massively by astrazeneca plc, chemocentryx inc, dompe ... salisburyandstonehenge Fri, 01 Dec 2023 09:10:31 GMT
• tavneos plus rituximab induction aids sustained remission with aav ANCA Vasculitis News Mon, 27 Nov 2023 13:13:29 GMT
• c-c chemokine receptor type 4 market analysis, competitors, growth rate 2023 | chemocentryx inc, corion biotech ... Argyle Report Sun, 26 Nov 2023 09:48:43 GMT
• microscopic polyangiitis (mpa) treatment market scope – celltrion inc, chemocentryx inc, sandoz international ... Argyle Report Mon, 20 Nov 2023 04:44:26 GMT
• atypical chemokine receptor 3 industry analysis | chemocentryx inc, jyant technologies inc, polyphor ltd – argyle ... Argyle Report Sat, 18 Nov 2023 05:49:35 GMT
• complement 3 glomerulopathy market to witness an upsurge in ... GlobeNewswire Mon, 06 Nov 2023 08:00:00 GMT
• myeloid cells targeting therapeutics market see huge growth for new normal | chemocentryx, daiichi sankyo ... Argyle Report Wed, 01 Nov 2023 13:53:27 GMT
• With Tepezza sales still stagnant, Amgen has a plan to boost the newly acquired TED drug Fierce Pharma Tue, 31 Oct 2023 07:00:00 GMT
• microscopic polyangiitis market top-vendor and industry analysis by end-user segments till 2030 | genentech, inc ... Digital Journal Thu, 26 Oct 2023 10:46:44 GMT
• mironid appoints dr catherine kelleher as chief medical officer GlobeNewswire Tue, 24 Oct 2023 07:00:00 GMT
• mironid appoints dr catherine kelleher as chief medical officer Yahoo Finance Mon, 23 Oct 2023 07:00:00 GMT
• Chemocentryx presents new chemokine CXCR6 receptor antagonists BioWorld MedTech Fri, 20 Oct 2023 07:00:00 GMT
• mid-peninsula project rode biotech's boom. now it's showing how to ... The Business Journals Thu, 12 Oct 2023 07:00:00 GMT
• chemocentryx's avacopan may need another trial after tepid advisory committee vote Pink Sheet Wed, 11 Oct 2023 21:57:56 GMT
• changing standards of care trip up companies at us fda advisory committees Pink Sheet Fri, 06 Oct 2023 13:11:14 GMT
• after short ftc fight, amgen wraps up $27.8b horizon buyout FiercePharma Fri, 06 Oct 2023 07:00:00 GMT
• outcome measures for the evaluation of treatment response in ... JAMA Network Wed, 27 Sep 2023 07:00:00 GMT
• market pulse-gold miners, tower financial, conagra, chemocentryx Reuters Sun, 10 Sep 2023 07:00:00 GMT
• market pulse-tower financial, conagra, chemocentryx, nanostring, crocs Reuters Sun, 10 Sep 2023 07:00:00 GMT
• 'we should be thinking cure' for giant cell, takayasu arteritis as trial ... Healio Sat, 09 Sep 2023 07:00:00 GMT
• new trials, therapies to address unmet needs in anca-associated ... Healio Sat, 09 Sep 2023 07:00:00 GMT
• ftc settlement could shelter amgen from us price cuts, taxes Reuters Tue, 05 Sep 2023 07:00:00 GMT
• amgen clear to acquire horizon after agreement with federal trade ... Healio Fri, 01 Sep 2023 07:00:00 GMT
• tausif ('tosh') butt to join idorsia pharmaceuticals u.s. as president ... PR Newswire Thu, 31 Aug 2023 07:00:00 GMT
• tavneos better than prednisone at offering quality of life:... ANCA Vasculitis News Wed, 26 Jul 2023 07:00:00 GMT
• anca associated vasculitis industry & epidemiology analysis and ... Yahoo Finance Fri, 21 Jul 2023 07:00:00 GMT
• tavneos (avacopan) for anca-associated vasculitis ANCA Vasculitis News Mon, 26 Jun 2023 07:00:00 GMT
• nexcella appoints henry mckinnell, jr., former chairman & ceo of pfizer inc., to board of directors GlobeNewswire Mon, 12 Jun 2023 07:00:00 GMT
• safety and activity of immune checkpoint inhibitors in people living ... ASCO Journals Tue, 16 May 2023 07:00:00 GMT
• amgen drops drug delivery partnership, targets crohn’s disease ... BioSpace Wed, 10 May 2023 07:00:00 GMT
• spotlight – travere trips up but others are following in rare kidney disease Evaluate Pharma Fri, 05 May 2023 07:00:00 GMT
• after 2022's m&a spree, amgen ceo robert bradway collects $21.4m payday FiercePharma Fri, 07 Apr 2023 07:00:00 GMT
• chemocentryx inc - company profile - market research reports & consulting GlobalData Sat, 01 Apr 2023 07:00:00 GMT
• us doctors excited by tavneos' potential to cut steroid use:... ANCA Vasculitis News Mon, 13 Mar 2023 07:00:00 GMT
• vfmcrp and chemocentryx report positive data for avacopan Clinical Trials Arena Thu, 09 Mar 2023 08:00:00 GMT
• tavneos' use by aav patients prior to its approval support safety... ANCA Vasculitis News Wed, 01 Mar 2023 08:00:00 GMT
• tavneos superior to steroids at reversing severe kidney disease |... ANCA Vasculitis News Mon, 13 Feb 2023 08:00:00 GMT
• hidradenitis suppurativa market is expected to grow at a significant ... PR Newswire Wed, 11 Jan 2023 08:00:00 GMT
• amgen boasts lucrative acquisitions, drug updates, burgeoning biosimilars at jpm BioSpace Tue, 10 Jan 2023 08:00:00 GMT
• life sciences m&a: investment lifecycle optimization Alvarez & Marsal Tue, 10 Jan 2023 08:00:00 GMT
• provention bio onboards rita jain, m.d., to board of directors World Business Outlook Fri, 06 Jan 2023 08:00:00 GMT
• provention bio appoints rita jain to board of directors Indian Pharma Post Fri, 06 Jan 2023 08:00:00 GMT
• provention bio appoints rita jain, m.d., to board of directors citybiz Thu, 05 Jan 2023 08:00:00 GMT
• provention bio announces appointment of rita jain, m.d., to board of directors PR Newswire Thu, 05 Jan 2023 08:00:00 GMT
• rituximab treatment effective in disease remission in aav: study |... ANCA Vasculitis News Mon, 02 Jan 2023 08:00:00 GMT
• 2022 turns out to be another unspectacular year for pharma and ... The Pharma Letter Mon, 02 Jan 2023 08:00:00 GMT
• chemocentryx inc - company profile - market research reports & consulting GlobalData Mon, 26 Dec 2022 21:22:33 GMT
• amgen targets rare diseases with acquisition BioStock - Connecting Innovation and Capital Thu, 15 Dec 2022 08:00:00 GMT
• amgen to buy horizon for nearly $28 billion Chemical & Engineering News Tue, 13 Dec 2022 08:00:00 GMT
• biotech company amgen to buy drug firm horizon | arkansas democrat gazette Arkansas Online Tue, 13 Dec 2022 08:00:00 GMT
• amgen to buy horizon therapeutics in $26.4-billion deal Los Angeles Times Mon, 12 Dec 2022 08:00:00 GMT
• amgen dives deeper into rare disease drugs with $27.8 bln horizon deal Reuters Mon, 12 Dec 2022 08:00:00 GMT
• amgen to buy horizon therapeutics in year's biggest biotech deal Healthcare Dive Mon, 12 Dec 2022 08:00:00 GMT
• horizon therapeutics fields buyout interest from amgen, j&j and sanofi Reuters Tue, 29 Nov 2022 08:00:00 GMT
• amgn: 2 biotech stocks to buy in november and 1 to sell StockNews.com Mon, 21 Nov 2022 08:00:00 GMT
• in jazz case, ftc urges court to delist patent on xyrem FiercePharma Mon, 14 Nov 2022 08:00:00 GMT
• clinical signs differ between kids and adults with vasculitis Medscape Sat, 12 Nov 2022 08:00:00 GMT
• amgen’s latest acquisition puts a spotlight on rare autoimmune disease Amgen Thu, 10 Nov 2022 08:00:00 GMT
• amgen's latest acquisition puts a spotlight on rare autoimmune disease Amgen Thu, 10 Nov 2022 08:00:00 GMT
• biotech win: amgen beats street again San Fernando Valley Business Journal Tue, 08 Nov 2022 08:00:00 GMT
• Amgen Acquires ChemoCentryx, AAV Therapy Tavneos ANCA Vasculitis News Mon, 24 Oct 2022 07:00:00 GMT
• amgen acquires chemocentryx, aav therapy tavneos | anca vasculitis... ANCA Vasculitis News Mon, 24 Oct 2022 07:00:00 GMT
• amgen completes purchase of chemocentryx for $3.7 billion The Business Journals Fri, 21 Oct 2022 07:00:00 GMT
• amgen completes acquisition of chemocentryx in deal worth $3.7bn PMLiVE Fri, 21 Oct 2022 07:00:00 GMT
• avacopan, rituximab allow for reduced glucocorticoid use in anca ... Healio Fri, 21 Oct 2022 07:00:00 GMT
• amgen successfully completes acquisition of chemocentryx PR Newswire Thu, 20 Oct 2022 07:00:00 GMT
• chemocentryx shareholders approve $3.7b merger with amgen (nasdaq:ccxi) Seeking Alpha Tue, 18 Oct 2022 07:00:00 GMT
ChemoCentryx, Inc(NASDAQ:CCXI) 
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibito...
Website: http://www.chemocentryx.com
Founded: 1996
Full Time Employees: 133 (May 2021)
Sector: Healthcare
Industry: Biotechnology